Hypermethylation of ERα gene was reported to be an important cause of suppressed ERα expression (9, 11), and the combination of DNA demethylating agents with HDAC inhibitors would restore ERα expression and TAM sensitivity in ERα− BC cells (12, 13). The gene discussed is HDAC9; the disease is breast cancer.